Use of Immunohistochemical and Molecular Studies in the Evaluation of the Sebaceous Neoplasms

[1]  S. Suster,et al.  Role of Immunohistochemistry in the Diagnosis of Sebaceous Carcinoma: A Clinicopathologic and Immunohistochemical Study , 2015, The American Journal of dermatopathology.

[2]  M. Bajaj,et al.  ZEB2/SIP1 as novel prognostic indicator in eyelid sebaceous gland carcinoma. , 2015, Human pathology.

[3]  S. Richman.  Deficient mismatch repair: Read all about it (Review) , 2015, International journal of oncology.

[4]  J. Kim,et al.  Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target , 2015, Journal of Cancer Research and Clinical Oncology.

[5]  V. White,et al.  Sebaceous carcinoma: clinicopathologic features and diagnostic role of immunohistochemistry (including androgen receptor). , 2014, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[6]  P. Aung,et al.  Extraocular sebaceous carcinoma in situ: report of three cases and review of the literature , 2014, Journal of cutaneous pathology.

[7]  T. Milman,et al.  Diagnostic utility of adipophilin immunostain in periocular carcinomas. , 2014, Ophthalmology.

[8]  D. Elston,et al.  Secondary neoplasms associated with nevus sebaceus of Jadassohn: a study of 707 cases. , 2014, Journal of the American Academy of Dermatology.

[9]  F. Jakobiec,et al.  Eyelid sebaceous carcinoma: clinicopathologic and multiparametric immunohistochemical analysis that includes adipophilin. , 2014, American journal of ophthalmology.

[10]  H. Choung,et al.  Expression of cell cycle regulatory proteins in eyelid sebaceous gland carcinoma: low p27 expression predicts poor prognosis. , 2014, Experimental eye research.

[11]  E. Wolf,et al.  Ligand‐independent epidermal growth factor receptor hyperactivation increases sebaceous gland size and sebum secretion in mice , 2013, Experimental dermatology.

[12]  M. Hoang,et al.  Perilipin and adipophilin expression in sebaceous carcinoma and mimics. , 2013, Human pathology.

[13]  Jianping Li,et al.  Lipid synthesis and processing proteins ABHD5, PGRMC1 and squalene synthase can serve as novel immunohistochemical markers for sebaceous neoplasms and differentiate sebaceous carcinoma from sebaceoma and basal cell carcinoma with clear cell features , 2013, Journal of cutaneous pathology.

[14]  S. Mane,et al.  Whole exome sequencing reveals somatic mutations in HRAS and KRAS which cause nevus sebaceus , 2012, The Journal of investigative dermatology.

[15]  M. Heckman,et al.  Screening for Muir-Torre Syndrome Using Mismatch Repair Protein Immunohistochemistry of Sebaceous Neoplasms , 2013, Journal of Genetic Counseling.

[16]  S. Arase,et al.  Sebaceous Carcinoma: An Immunohistochemical Reappraisal , 2011, The American Journal of dermatopathology.

[17]  R. Happle.  The group of epidermal nevus syndromes Part I. Well defined phenotypes. , 2010, Journal of the American Academy of Dermatology.

[18]  R. Shahsiah,et al.  Comparative examination of androgen receptor reactivity for differential diagnosis of sebaceous carcinoma from squamous cell and basal cell carcinoma. , 2010, American journal of clinical pathology.

[19]  D. Krahl,et al.  Basal cell carcinoma and pilomatrixoma mirror human follicular embryogenesis as reflected by their differential expression patterns of SOX9 and β‐catenin , 2010, The British journal of dermatology.

[20]  A. Lazar,et al.  Adipophilin expression in sebaceous tumors and other cutaneous lesions with clear cell histology: an immunohistochemical study of 117 cases , 2010, Modern Pathology.

[21]  A. Lazar,et al.  Epidermal growth factor receptor (EGFR) expression in periocular and extraocular sebaceous carcinoma , 2010, Journal of cutaneous pathology.

[22]  A. Warth,et al.  Lipid droplet-associated PAT-proteins show frequent and differential expression in neoplastic steatogenesis , 2010, Modern Pathology.

[23]  A. Lazar,et al.  Sebaceous neoplasia and the Muir–Torre syndrome: important connections with clinical implications , 2010, Histopathology.

[24]  S. Yokoyama,et al.  Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid. , 2010, Investigative ophthalmology & visual science.

[25]  M. Mahalingam,et al.  Cutaneous sebaceous neoplasms as markers of Muir‐Torre syndrome: a diagnostic algorithm , 2009, Journal of cutaneous pathology.

[26]  Laura H. Tang,et al.  Towards Identification of Hereditary DNA Mismatch Repair Deficiency: Sebaceous Neoplasm Warrants Routine Immunohistochemical Screening Regardless of Patient's Age or Other Clinical Characteristics , 2009, The American journal of surgical pathology.

[27]  H. Kutzner,et al.  Discordant Architectural and Cytological Features in Cutaneous Sebaceous Neoplasms-A Classification Dilemma: Report of 5 Cases , 2009, The American Journal of dermatopathology.

[28]  L. Wilson,et al.  A retrospective review of 1349 cases of sebaceous carcinoma , 2009, Cancer.

[29]  G. Berx,et al.  The role of the ZEB family of transcription factors in development and disease , 2009, Cellular and Molecular Life Sciences.

[30]  D. Cassarino,et al.  Immunohistochemical Expression of D2-40 in Benign and Malignant Sebaceous Tumors and Comparison to Basal and Squamous Cell Carcinomas , 2008, The American Journal of dermatopathology.

[31]  H. Cualing,et al.  Immunohistochemical Expression of Survivin in Cutaneous Sebaceous Lesions , 2008, The American Journal of dermatopathology.

[32]  C. Nazario,et al.  MSH-2 and MLH-1 protein expression in Muir Torre syndrome-related and sporadic sebaceous neoplasms. , 2008, Puerto Rico health sciences journal.

[33]  T. Nagai,et al.  Ten cases of sebaceous carcinoma arising in nevus sebaceus , 2008, The Journal of dermatology.

[34]  E. Cesarman,et al.  The pathobiology of Kaposi’s sarcoma: advances since the onset of the AIDS epidemic , 2008, Journal of cutaneous pathology.

[35]  A. Lazar,et al.  Site and Tumor Type Predicts DNA Mismatch Repair Status in Cutaneous Sebaceous Neoplasia , 2008, The American journal of surgical pathology.

[36]  F. Watt,et al.  Characterization of Bipotential Epidermal Progenitors Derived from Human Sebaceous Gland: Contrasting Roles of c‐Myc and β‐Catenin , 2008, Stem cells.

[37]  M. Mahalingam,et al.  MSH-6: extending the reliability of immunohistochemistry as a screening tool in Muir–Torre syndrome , 2008, Modern Pathology.

[38]  D. Mehregan,et al.  Immunolabeling pattern of cytokeratin 19 expression may distinguish sebaceous tumors from basal cell carcinomas , 2007, Journal of cutaneous pathology.

[39]  P. Peltomäki,et al.  Lynch syndrome and related familial colorectal cancers. , 2008, Critical reviews in oncogenesis.

[40]  O. Huber,et al.  The tumor suppressor Fhit acts as a repressor of β-catenin transcriptional activity , 2007, Proceedings of the National Academy of Sciences.

[41]  H. Ananthaswamy,et al.  p53 and the pathogenesis of skin cancer. , 2007, Toxicology and applied pharmacology.

[42]  A. Cesinaro,et al.  Mismatch Repair Proteins Expression and Microsatellite Instability in Skin Lesions With Sebaceous Differentiation: A Study in Different Clinical Subgroups With and Without Extracutaneous Cancer , 2007, The American Journal of dermatopathology.

[43]  E. Calonje,et al.  Characteristic Ber‐EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma , 2007, Histopathology.

[44]  C. Longo,et al.  BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-associated polyposis pedigrees. , 2007, The Journal of investigative dermatology.

[45]  E. Calonje,et al.  Sebaceous Carcinoma Arising in Nevus Sebaceus of Jadassohn: A Clinicopathological Study of Five Cases , 2007, The American Journal of dermatopathology.

[46]  F. Watt,et al.  Dual role of inactivating Lef1 mutations in epidermis: tumor promotion and specification of tumor type. , 2007, Cancer research.

[47]  D. Cassarino,et al.  Distinction of Benign Sebaceous Proliferations From Sebaceous Carcinomas by Immunohistochemistry , 2006, The American Journal of dermatopathology.

[48]  Andrew G Smith,et al.  Sebaceous hyperplasia and skin cancer in patients undergoing renal transplant. , 2006, Journal of the American Academy of Dermatology.

[49]  Y. Narisawa,et al.  Cytokeratin 15 expression in neoplasms with sebaceous differentiation , 2006, Journal of cutaneous pathology.

[50]  C. Prins,et al.  An illustrative case of Muir-Torre syndrome: contribution of immunohistochemical analysis in identifying indicator sebaceous lesions. , 2006, Archives of dermatology.

[51]  Ian Smyth,et al.  Human sebaceous tumors harbor inactivating mutations in LEF1 , 2006, Nature Medicine.

[52]  K. Muthusamy,et al.  Immunohistochemical staining for adipophilin, perilipin and TIP47 , 2006, Journal of Clinical Pathology.

[53]  L. Holbach,et al.  Different genetic pathways in the development of periocular sebaceous gland carcinomas in presumptive Muir‐Torre syndrome patients , 2006, Human mutation.

[54]  M. Ponz de Leòn,et al.  Muir-Torre syndrome. , 2005, The Lancet. Oncology.

[55]  M. Kakibuchi,et al.  Sebaceous Carcinoma Arising in Nevus Sebaceus , 2005, The Journal of dermatology.

[56]  Pang Sm,et al.  Cyclosporin-induced sebaceous hyperplasia in renal transplant patients. , 2005 .

[57]  M. Michal,et al.  Ectopic sebaceous glands in the vagina. , 2005, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[58]  C. Shields,et al.  Sebaceous carcinoma of the eyelids: personal experience with 60 cases. , 2004, Ophthalmology.

[59]  R. Happle.  Gustav Schimmelpenning and the Syndrome Bearing His Name , 2004, Dermatology.

[60]  R. Kruse,et al.  DNA mismatch repair and the significance of a sebaceous skin tumor for visceral cancer prevention. , 2004, Trends in molecular medicine.

[61]  Sudhir Srivastava,et al.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.

[62]  H. Kıran,et al.  Sebaceous gland hyperplasia of the vulva , 2004, The Australian & New Zealand journal of obstetrics & gynaecology.

[63]  M. Genuardi,et al.  Hereditary nonpolyposis colorectal cancer and related conditions , 2003, American journal of medical genetics. Part A.

[64]  S. Lyle,et al.  Keratin 15 promoter targets putative epithelial stem cells in the hair follicle bulge. , 2003, The Journal of investigative dermatology.

[65]  F M Watt,et al.  Indian hedgehog and β-catenin signaling: Role in the sebaceous lineage of normal and neoplastic mammalian epidermis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[66]  A. Hauschild,et al.  The sebaceous nevus as part of the Schimmelpenning–Feuerstein–Mims Syndrome – an obvious phacomatosis first documented in 1927 , 2003, Journal of cutaneous pathology.

[67]  P. Propping,et al.  Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias. , 2003, The Journal of investigative dermatology.

[68]  P. Peltomäki.  Role of DNA mismatch repair defects in the pathogenesis of human cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[69]  Z. Gatalica,et al.  Loss of mismatch repair proteins in sebaceous gland tumors , 2003, Journal of cutaneous pathology.

[70]  W. Krause,et al.  Areolar sebaceous hyperplasia. , 2003, Acta dermato-venereologica.

[71]  N. Reynolds,et al.  Loss of p21WAF1 compartmentalisation in sebaceous carcinoma compared with sebaceous hyperplasia and sebaceous adenoma , 2002, Journal of clinical pathology.

[72]  Y. Narisawa,et al.  Sebaceoma and Related Neoplasms With Sebaceous Differentiation: A Clinicopathologic Study of 30 Cases , 2002, The American Journal of dermatopathology.

[73]  L. Holbach,et al.  Loss of fragile histidine triad (FHIT) expression and microsatellite instability in periocular sebaceous gland carcinoma in patients with Muir-Torre syndrome. , 2002, American journal of ophthalmology.

[74]  S. Chang,et al.  Clinical and Histologic Features of 64 Cases of Steatocystoma Multiplex , 2002, The Journal of dermatology.

[75]  W. Birchmeier,et al.  Expression of DeltaNLef1 in mouse epidermis results in differentiation of hair follicles into squamous epidermal cysts and formation of skin tumours. , 2002, Development.

[76]  M. Takata,et al.  No evidence of deregulated patched-hedgehog signaling pathway in trichoblastomas and other tumors arising within nevus sebaceous. , 2001, The Journal of investigative dermatology.

[77]  Y. Narisawa,et al.  Rippled-pattern Sebaceoma , 2001, The American Journal of dermatopathology.

[78]  C. Croce,et al.  Fragile histidine triad gene and skin cancer. , 2001, European journal of dermatology : EJD.

[79]  P. Propping,et al.  "Second hit" in sebaceous tumors from Muir-Torre patients with germline mutations in MSH2: allele loss is not the preferred mode of inactivation. , 2001, The Journal of investigative dermatology.

[80]  P. Shepherd,et al.  Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin , 2000, Histopathology.

[81]  B. Cribier,et al.  Tumors arising in nevus sebaceus: A study of 596 cases. , 2000, Journal of the American Academy of Dermatology.

[82]  B. Smoller,et al.  Immunohistochemical staining for androgen receptors: a sensitive marker of sebaceous differentiation. , 1999, The American Journal of dermatopathology.

[83]  G. Burg,et al.  The sebaceous nevus: a nevus with deletions of the PTCH gene. , 1999, Cancer research.

[84]  Munro,et al.  Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2 , 1998, The British journal of dermatology.

[85]  B. P. Warrenburg,et al.  The linear naevus sebaceus syndrome , 1998, Clinical Neurology and Neurosurgery.

[86]  P. Levine,et al.  Sebaceous carcinoma: Tumor progression through mutational inactivation of p53 , 1998 .

[87]  J. Rüschoff,et al.  Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. , 1997, Cancer research.

[88]  E. Alessi,et al.  Simultaneous occurrence of multiple trichoblastomas and steatocystoma multiplex. , 1997, The American Journal of dermatopathology.

[89]  E. Lane,et al.  Missense mutations in keratin 17 cause either pachyonychia congenita type 2 or a phenotype resembling steatocystoma multiplex. , 1997, The Journal of investigative dermatology.

[90]  R. Schwartz,et al.  The Muir-Torre syndrome: a 25-year retrospect. , 1995, Journal of the American Academy of Dermatology.

[91]  M. Iwasaki,et al.  Ectopic sebaceous glands in the esophagus. , 1995, The American journal of gastroenterology.

[92]  A. Ackerman,et al.  Neoplasms with sebaceous differentiation , 1994 .

[93]  Y. Shimosato,et al.  Prognostic value of immunohistochemical staining for proliferating cell nuclear antigen, p53, and c-erbB-2 in sebaceous gland carcinoma and sweat gland carcinoma: comparison with histopathological parameter. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[94]  T. Daley.  Intraoral sebaceous hyperplasia. Diagnostic criteria. , 1993, Oral surgery, oral medicine, and oral pathology.

[95]  D. Arnstein,et al.  Sebaceous carcinoma of the head and neck. Case report and literature review. , 1992, Archives of otolaryngology--head & neck surgery.

[96]  G. López-García,et al.  Sebaceous glands and hair follices in the cervix uteri , 1992, Histopathology.

[97]  L. Requena,et al.  Plate‐like sebaceous hyperplasia overlying dermatofibroma , 1992, Journal of cutaneous pathology.

[98]  T. H. van der Kwast,et al.  Androgen receptor expression in human tissues: an immunohistochemical study. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[99]  Philip R. Cohen,et al.  Association of Sebaceous Gland Tumors and Internal Malignancy: The Muir-Torre Syndrome , 1991 .

[100]  Yuh-Chyuang Tsai,et al.  Jadassohn's Nevus Sebaceous of the Head and Face , 1990, Annals of plastic surgery.

[101]  P. M. Catalano,et al.  Areolar sebaceous hyperplasia. , 1985, Journal of the American Academy of Dermatology.

[102]  G. A. Rosenblum.  Nevus sebaceus, syringocystadenoma papilliferum, and basal cell epithelioma. , 1985, The Journal of dermatologic surgery and oncology.

[103]  M. Wick,et al.  Adnexal carcinomas of the skin II. Extraocular sebaceous carcinomas , 1985, Cancer.

[104]  S. Morioka.  The natural history of nevus sebaceus , 1985, Journal of cutaneous pathology.

[105]  R. Waller,et al.  Sebaceous carcinoma of the eyelid: pitfalls in diagnosis. , 1985 .

[106]  Ackerman Ab,et al.  Sebaceoma. A distinctive benign neoplasm of adnexal epithelium differentiating toward sebaceous cells. , 1984 .

[107]  I. McLean,et al.  Sebaceous carcinomas of the ocular adnexa: A clinicopathologic study of 104 cases, with five-year follow-up data. , 1982, Human pathology.

[108]  A. Mehregan,et al.  Benigh epithelial tumors of the skin. II: benign sebaceous tumors. , 1977, Cutis.

[109]  Arnold Hl.  Letter: Fordyce spots. , 1974 .

[110]  E. B. Helwig,et al.  Cutaneous sebaceous neoplasms , 1974, Cancer.

[111]  A. Hyman,et al.  Tyson's "glands." Ectopic sebaceous glands and papillomatosis penis. , 1969, Archives of dermatology.

[112]  D. Torre.  Multiple sebaceous tumors. , 1968, Archives of dermatology.

[113]  E. Muir,et al.  Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato‐acanthomata of the face , 1967, The British journal of surgery.

[114]  H. Pinkus,et al.  LIFE HISTORY OF ORGANOID NEVI. SPECIAL REFERENCE TO NEVUS SEBACEUS OF JADASSOHN. , 1965, Archives of dermatology.

[115]  R. C. Feuerstein,et al.  Linear nevus sebaceus with convulsions and mental retardation. , 1962, American journal of diseases of children.